Lista de obras - Patricia L Winokur - Dominio Público Uruguay

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects

artículo científico publicado en 2009

A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.

artículo científico publicado en 2018

Active choice but not too active: public perspectives on biobank consent models.

artículo científico publicado en 2011

Analysis of nontypeable haemophilus influenzae phase-variable genes during experimental human nasopharyngeal colonization

artículo científico publicado en 2013

Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.

artículo científico publicado en 2000

Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles ⬇️

artículo científico publicado el 1 de febrero de 1993

Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004.

scientific article published on June 2007

Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)

scientific article published on 01 December 1998

Association between ceftiofur use and isolation of Escherichia coli with reduced susceptibility to ceftriaxone from fecal samples of dairy cows.

artículo científico publicado en 2006

Association between microbial characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study

artículo científico publicado en 2015

BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin

artículo científico publicado en 2009

CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination

artículo científico publicado en 2017

Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan

artículo científico publicado en 2002

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

artículo científico publicado en 2015

Characterization of extended spectrum beta-lactamase-producing Klebsiella pneumoniae from Beijing, China.

artículo científico publicado en 2001

Community-associated methicillin-resistant Staphylococcus aureus, Iowa, USA.

artículo científico publicado en 2009

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

artículo científico publicado en 2015

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults

artículo científico publicado en 2011

Confirmation of extended-spectrum beta-lactamase-producing Serratia marcescens: preliminary report from Taiwan

artículo científico publicado en 2003

DNA sequence analysis of regions surrounding blaCMY-2 from multiple Salmonella plasmid backbones.

artículo científico publicado en 2004

Development of a prediction rule for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus carriage in a Veterans Affairs Medical Center population

artículo científico publicado en 2008

Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections

artículo científico publicado en 2007

Emergence of the USA300 Strain of Methicillin-Resistant Staphylococcus aureus in a Burn-Trauma Unit

article

Emergence of two Klebsiella pneumoniae isolates harboring plasmid-mediated CTX-M-15 beta-lactamase in Taiwan

artículo científico publicado en 2004

First description of Klebsiella pneumoniae harboring CTX-M beta-lactamases (CTX-M-14 and CTX-M-3) in Taiwan

artículo científico publicado en 2002

Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial

artículo científico publicado en 2012

Identification of Single Amino Acids in the Human Papillomavirus 11 E2 Protein Critical for the Transactivation or Replication Functions

artículo científico publicado en 1998

Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older

artículo científico publicado en 2021

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons

artículo científico publicado en 2012

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial

artículo científico

Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine

scientific article published on 02 June 2008

Immunoglobulin prophylaxis for hepatitis A

artículo científico publicado el 1 de febrero de 1992

Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA(1).

artículo científico publicado en 2016

Long-term risk for readmission, methicillin-resistant Staphylococcus aureus (MRSA) infection, and death among MRSA-colonized veterans

artículo científico publicado en 2012

Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.

artículo científico publicado en 2012

Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals

artículo científico publicado en 2014

Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans

artículo científico publicado en 2003

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

artículo científico publicado en 2014

Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin

artículo científico publicado en 2008

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination

artículo científico publicado en 2016

Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

artículo científico publicado en 2017

Rapid, Culture-Free Detection of Staphylococcus aureus Bacteremia

artículo científico publicado en 2016

Recombinant Hepatitis A Virus Antigen: Improved Production and Utility in Diagnostic Immunoassays ⬇️

artículo científico publicado el 1 de julio de 1998

Reducing the Dose of Smallpox Vaccine Reduces Vaccine‐Associated Morbidity without Reducing Vaccination Success Rates or Immune Responses

article

Russian Klebsiella pneumoniae isolates that express extended-spectrum beta-lactamases.

artículo científico publicado en 2000

Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.

artículo científico publicado en 2014

Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules

artículo científico publicado en 2016

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.

artículo científico publicado en 2015

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

artículo científico publicado en 2015

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

artículo científico publicado en 2012

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

artículo científico publicado en 2013

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects

artículo científico publicado en 2007

Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial

artículo científico

Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults

artículo científico publicado en 2009

Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae

artículo científico publicado en 2013

Separation of the transcriptional activation and replication functions of the bovine papillomavirus-1 E2 protein ⬇️

artículo científico publicado el 1 de noviembre de 1992

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial

artículo científico

Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection

artículo científico publicado en 2008

Surveillance in Taiwan using molecular epidemiology for extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.

artículo científico publicado en 2004

The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into viruslike particles ⬇️

artículo científico publicado el 1 de septiembre de 1991

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial

artículo científico publicado en 2017

Use of Molecular and Reference Susceptibility Testing Methods in a Multicenter Evaluation of MicroScan Dried Overnight Gram-Positive MIC Panels for Detection of Vancomycin and High-Level Aminoglycoside Resistances in Enterococci ⬇️

artículo científico publicado el 1 de octubre de 1998

Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial

artículo científico publicado en 2004

Lista de obras de Patricia L Winokur

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects

A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.

Active choice but not too active: public perspectives on biobank consent models.

Analysis of nontypeable haemophilus influenzae phase-variable genes during experimental human nasopharyngeal colonization

Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.

Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles ⬇️

Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004.

Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)

Association between ceftiofur use and isolation of Escherichia coli with reduced susceptibility to ceftriaxone from fecal samples of dairy cows.

Association between microbial characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study

BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin

CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination

Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

Characterization of extended spectrum beta-lactamase-producing Klebsiella pneumoniae from Beijing, China.

Community-associated methicillin-resistant Staphylococcus aureus, Iowa, USA.

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults

Confirmation of extended-spectrum beta-lactamase-producing Serratia marcescens: preliminary report from Taiwan

DNA sequence analysis of regions surrounding blaCMY-2 from multiple Salmonella plasmid backbones.

Development of a prediction rule for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus carriage in a Veterans Affairs Medical Center population

Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections

Emergence of the USA300 Strain of Methicillin-Resistant Staphylococcus aureus in a Burn-Trauma Unit

Emergence of two Klebsiella pneumoniae isolates harboring plasmid-mediated CTX-M-15 beta-lactamase in Taiwan

First description of Klebsiella pneumoniae harboring CTX-M beta-lactamases (CTX-M-14 and CTX-M-3) in Taiwan

Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial

Identification of Single Amino Acids in the Human Papillomavirus 11 E2 Protein Critical for the Transactivation or Replication Functions

Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial

Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine

Immunoglobulin prophylaxis for hepatitis A

Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA(1).

Long-term risk for readmission, methicillin-resistant Staphylococcus aureus (MRSA) infection, and death among MRSA-colonized veterans

Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.

Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals

Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination

Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Rapid, Culture-Free Detection of Staphylococcus aureus Bacteremia

Recombinant Hepatitis A Virus Antigen: Improved Production and Utility in Diagnostic Immunoassays ⬇️

Reducing the Dose of Smallpox Vaccine Reduces Vaccine‐Associated Morbidity without Reducing Vaccination Success Rates or Immune Responses

Russian Klebsiella pneumoniae isolates that express extended-spectrum beta-lactamases.

Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.

Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects

Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial

Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults

Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae

Separation of the transcriptional activation and replication functions of the bovine papillomavirus-1 E2 protein ⬇️

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial

Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection

Surveillance in Taiwan using molecular epidemiology for extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.

The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into viruslike particles ⬇️

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial

Use of Molecular and Reference Susceptibility Testing Methods in a Multicenter Evaluation of MicroScan Dried Overnight Gram-Positive MIC Panels for Detection of Vancomycin and High-Level Aminoglycoside Resistances in Enterococci ⬇️

Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial

Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine